EMEA (Europe, Middle East and Africa) Anthrax Vaccines Market Report 2018

June 2018 | 126 pages | ID: E85AF3264AAEN
QYResearch

Abstracts

In this report, the EMEA Anthrax Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (M Doses), revenue (Million USD), market share and growth rate of Anthrax Vaccines for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anthrax Vaccines market competition by top manufacturers/players, with Anthrax Vaccines sales volume (M Doses), price (USD/Doses), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Emergent BioSolutions
• Merial
• Merck
• Zoetis
• Bayer Sanidad Animal
• Colorado Serum
• PharmAthene
• Tiankang
• Biogénesis-Bago
• CAVAC
• Rosenbusch
• Agrovet
• Vecol
• CVCRI
• IVPM
• Prondil
• CDV
• Indian Immunologicals
• Botswana Vaccine Institute
• Ceva Santé Animale
• Intervac
• JOVAC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Live Vaccines
• Cell free PA Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Human Use
• Animal Use

Contents

EMEA (Europe, Middle East and Africa) Anthrax Vaccines Market Report 2018

1 ANTHRAX VACCINES OVERVIEW

1.1 Product Overview and Scope of Anthrax Vaccines
1.2 Classification of Anthrax Vaccines
  1.2.1 EMEA Anthrax Vaccines Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Anthrax Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Live Vaccines
  1.2.4 Cell free PA Vaccines
1.3 EMEA Anthrax Vaccines Market by Application/End Users
  1.3.1 EMEA Anthrax Vaccines Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Human Use
  1.3.3 Animal Use
1.4 EMEA Anthrax Vaccines Market by Region
  1.4.1 EMEA Anthrax Vaccines Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Anthrax Vaccines (2013-2025)
  1.5.1 EMEA Anthrax Vaccines Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Anthrax Vaccines Revenue and Growth Rate (2013-2025)

2 EMEA ANTHRAX VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anthrax Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Anthrax Vaccines Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Anthrax Vaccines Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Anthrax Vaccines Sale Price by Players (2013-2018)
2.2 EMEA Anthrax Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anthrax Vaccines Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Anthrax Vaccines Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Anthrax Vaccines Sale Price by Type (2013-2018)
2.3 EMEA Anthrax Vaccines (Volume) by Application
2.4 EMEA Anthrax Vaccines (Volume and Value) by Region
  2.4.1 EMEA Anthrax Vaccines Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Anthrax Vaccines Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Anthrax Vaccines Sales Price by Region (2013-2018)

3 EUROPE ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anthrax Vaccines Sales and Value (2013-2018)
  3.1.1 Europe Anthrax Vaccines Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Anthrax Vaccines Revenue and Growth Rate (2013-2018)
3.2 Europe Anthrax Vaccines Sales and Market Share by Type
3.3 Europe Anthrax Vaccines Sales and Market Share by Application
3.4 Europe Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anthrax Vaccines Sales Volume by Countries (2013-2018)
  3.4.2 Europe Anthrax Vaccines Revenue by Countries (2013-2018)
  3.4.3 Germany Anthrax Vaccines Sales and Growth Rate (2013-2018)
  3.4.4 France Anthrax Vaccines Sales and Growth Rate (2013-2018)
  3.4.5 UK Anthrax Vaccines Sales and Growth Rate (2013-2018)
  3.4.6 Russia Anthrax Vaccines Sales and Growth Rate (2013-2018)
  3.4.7 Italy Anthrax Vaccines Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Anthrax Vaccines Sales and Growth Rate (2013-2018)

4 MIDDLE EAST ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anthrax Vaccines Sales and Value (2013-2018)
  4.1.1 Middle East Anthrax Vaccines Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Anthrax Vaccines Revenue and Growth Rate (2013-2018)
4.2 Middle East Anthrax Vaccines Sales and Market Share by Type
4.3 Middle East Anthrax Vaccines Sales and Market Share by Application
4.4 Middle East Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anthrax Vaccines Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Anthrax Vaccines Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2013-2018)
  4.4.4 Israel Anthrax Vaccines Sales and Growth Rate (2013-2018)
  4.4.5 UAE Anthrax Vaccines Sales and Growth Rate (2013-2018)
  4.4.6 Iran Anthrax Vaccines Sales and Growth Rate (2013-2018)

5 AFRICA ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anthrax Vaccines Sales and Value (2013-2018)
  5.1.1 Africa Anthrax Vaccines Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Anthrax Vaccines Revenue and Growth Rate (2013-2018)
5.2 Africa Anthrax Vaccines Sales and Market Share by Type
5.3 Africa Anthrax Vaccines Sales and Market Share by Application
5.4 Africa Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anthrax Vaccines Sales Volume by Countries (2013-2018)
  5.4.2 Africa Anthrax Vaccines Revenue by Countries (2013-2018)
  5.4.3 South Africa Anthrax Vaccines Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Anthrax Vaccines Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Anthrax Vaccines Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Anthrax Vaccines Sales and Growth Rate (2013-2018)

6 EMEA ANTHRAX VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Emergent BioSolutions
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anthrax Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merial
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anthrax Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anthrax Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Zoetis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anthrax Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bayer Sanidad Animal
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anthrax Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Colorado Serum
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anthrax Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 PharmAthene
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anthrax Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Tiankang
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anthrax Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Biogénesis-Bago
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anthrax Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 CAVAC
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anthrax Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Rosenbusch
6.12 Agrovet
6.13 Vecol
6.14 CVCRI
6.15 IVPM
6.16 Prondil
6.17 CDV
6.18 Indian Immunologicals
6.19 Botswana Vaccine Institute
6.20 Ceva Santé Animale
6.21 Intervac
6.22 JOVAC

7 ANTHRAX VACCINES MANUFACTURING COST ANALYSIS

7.1 Anthrax Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anthrax Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anthrax Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTHRAX VACCINES MARKET FORECAST (2018-2025)

11.1 EMEA Anthrax Vaccines Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Anthrax Vaccines Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Anthrax Vaccines Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Anthrax Vaccines Price and Trend Forecast (2018-2025)
11.2 EMEA Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Anthrax Vaccines Sales Forecast by Type (2018-2025)
11.7 EMEA Anthrax Vaccines Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anthrax Vaccines
Figure EMEA Anthrax Vaccines Sales Volume (M Doses) by Type (2013-2025)
Figure EMEA Anthrax Vaccines Sales Volume Market Share by Type (Product Category) in 2017
Figure Live Vaccines Product Picture
Figure Cell free PA Vaccines Product Picture
Figure EMEA Anthrax Vaccines Sales Volume (M Doses) by Application (2013-2025)
Figure EMEA Sales Market Share of Anthrax Vaccines by Application in 2017
Figure Human Use Examples
Table Key Downstream Customer in Human Use
Figure Animal Use Examples
Table Key Downstream Customer in Animal Use
Figure EMEA Anthrax Vaccines Market Size (Million USD) by Region (2013-2025)
Figure Europe Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anthrax Vaccines Sales Volume and Growth Rate (2013-2025)
Figure EMEA Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Anthrax Vaccines Market Major Players Product Sales Volume (M Doses) (2013-2018)
Table EMEA Anthrax Vaccines Sales Volume (M Doses) of Major Players (2013-2018)
Table EMEA Anthrax Vaccines Sales Share by Players (2013-2018)
Figure 2017 Anthrax Vaccines Sales Share by Players
Figure 2017 Anthrax Vaccines Sales Share by Players
Figure EMEA Anthrax Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Anthrax Vaccines Revenue (Million USD) by Players (2013-2018)
Table EMEA Anthrax Vaccines Revenue Share by Players (2013-2018)
Table 2017 EMEA Anthrax Vaccines Revenue Share by Players
Table 2017 EMEA Anthrax Vaccines Revenue Share by Players
Table EMEA Anthrax Vaccines Sale Price (USD/Doses) by Players (2013-2018)
Table EMEA Anthrax Vaccines Sales (M Doses) and Market Share by Type (2013-2018)
Table EMEA Anthrax Vaccines Sales Share by Type (2013-2018)
Figure Sales Market Share of Anthrax Vaccines by Type (2013-2018)
Figure EMEA Anthrax Vaccines Sales Market Share by Type (2013-2018)
Table EMEA Anthrax Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Anthrax Vaccines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anthrax Vaccines by Type in 2017
Table EMEA Anthrax Vaccines Sale Price (USD/Doses) by Type (2013-2018)
Table EMEA Anthrax Vaccines Sales (M Doses) and Market Share by Application (2013-2018)
Table EMEA Anthrax Vaccines Sales Share by Application (2013-2018)
Figure Sales Market Share of Anthrax Vaccines by Application (2013-2018)
Figure EMEA Anthrax Vaccines Sales Market Share by Application in 2017
Table EMEA Anthrax Vaccines Sales (M Doses) and Market Share by Region (2013-2018)
Table EMEA Anthrax Vaccines Sales Share by Region (2013-2018)
Figure Sales Market Share of Anthrax Vaccines by Region (2013-2018)
Figure EMEA Anthrax Vaccines Sales Market Share in 2017
Table EMEA Anthrax Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Anthrax Vaccines Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Anthrax Vaccines by Region (2013-2018)
Figure EMEA Anthrax Vaccines Revenue Market Share Regions in 2017
Table EMEA Anthrax Vaccines Sales Price (USD/Doses) by Region (2013-2018)
Figure Europe Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Europe Anthrax Vaccines Revenue and Growth Rate (2013-2018)
Table Europe Anthrax Vaccines Sales (M Doses) by Type (2013-2018)
Table Europe Anthrax Vaccines Market Share by Type (2013-2018)
Figure Europe Anthrax Vaccines Market Share by Type in 2017
Table Europe Anthrax Vaccines Sales (M Doses) by Application (2013-2018)
Table Europe Anthrax Vaccines Market Share by Application (2013-2018)
Figure Europe Anthrax Vaccines Market Share by Application in 2017
Table Europe Anthrax Vaccines Sales (M Doses) by Countries (2013-2018)
Table Europe Anthrax Vaccines Sales Market Share by Countries (2013-2018)
Figure Europe Anthrax Vaccines Sales Market Share by Countries (2013-2018)
Figure Europe Anthrax Vaccines Sales Market Share by Countries in 2017
Table Europe Anthrax Vaccines Revenue (Million USD) by Countries (2013-2018)
Table Europe Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Europe Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Europe Anthrax Vaccines Revenue Market Share by Countries in 2017
Figure Germany Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure France Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure UK Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Russia Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Italy Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Benelux Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Middle East Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Middle East Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Anthrax Vaccines Sales (M Doses) by Type (2013-2018)
Table Middle East Anthrax Vaccines Market Share by Type (2013-2018)
Figure Middle East Anthrax Vaccines Market Share by Type (2013-2018)
Table Middle East Anthrax Vaccines Sales (M Doses) by Applications (2013-2018)
Table Middle East Anthrax Vaccines Market Share by Applications (2013-2018)
Figure Middle East Anthrax Vaccines Sales Market Share by Application in 2017
Table Middle East Anthrax Vaccines Sales Volume (M Doses) by Countries (2013-2018)
Table Middle East Anthrax Vaccines Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Anthrax Vaccines Sales Volume Market Share by Countries in 2017
Table Middle East Anthrax Vaccines Revenue (Million USD) by Countries (2013-2018)
Table Middle East Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East Anthrax Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Israel Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure UAE Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Iran Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Africa Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Africa Anthrax Vaccines Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Anthrax Vaccines Sales (M Doses) by Type (2013-2018)
Table Africa Anthrax Vaccines Sales Market Share by Type (2013-2018)
Figure Africa Anthrax Vaccines Sales Market Share by Type (2013-2018)
Figure Africa Anthrax Vaccines Sales Market Share by Type in 2017
Table Africa Anthrax Vaccines Sales (M Doses) by Application (2013-2018)
Table Africa Anthrax Vaccines Sales Market Share by Application (2013-2018)
Figure Africa Anthrax Vaccines Sales Market Share by Application (2013-2018)
Table Africa Anthrax Vaccines Sales Volume (M Doses) by Countries (2013-2018)
Table Africa Anthrax Vaccines Sales Market Share by Countries (2013-2018)
Figure Africa Anthrax Vaccines Sales Market Share by Countries (2013-2018)
Figure Africa Anthrax Vaccines Sales Market Share by Countries in 2017
Table Africa Anthrax Vaccines Revenue (Million USD) by Countries (2013-2018)
Table Africa Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Africa Anthrax Vaccines Revenue Market Share by Countries (2013-2018)
Figure Africa Anthrax Vaccines Revenue Market Share by Countries in 2017
Figure South Africa Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Nigeria Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Egypt Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Algeria Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Table Emergent BioSolutions Anthrax Vaccines Basic Information List
Table Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Emergent BioSolutions Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Emergent BioSolutions Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Emergent BioSolutions Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Merial Anthrax Vaccines Basic Information List
Table Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Merial Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Merial Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Merial Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Merck Anthrax Vaccines Basic Information List
Table Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Merck Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Merck Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Merck Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Zoetis Anthrax Vaccines Basic Information List
Table Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Zoetis Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Zoetis Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Zoetis Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Bayer Sanidad Animal Anthrax Vaccines Basic Information List
Table Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Bayer Sanidad Animal Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Bayer Sanidad Animal Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Colorado Serum Anthrax Vaccines Basic Information List
Table Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Colorado Serum Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Colorado Serum Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Colorado Serum Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table PharmAthene Anthrax Vaccines Basic Information List
Table PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure PharmAthene Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure PharmAthene Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure PharmAthene Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Tiankang Anthrax Vaccines Basic Information List
Table Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Tiankang Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Tiankang Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Tiankang Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Biogénesis-Bago Anthrax Vaccines Basic Information List
Table Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Biogénesis-Bago Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure Biogénesis-Bago Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure Biogénesis-Bago Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table CAVAC Anthrax Vaccines Basic Information List
Table CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure CAVAC Anthrax Vaccines Sales (M Doses) and Growth Rate (2013-2018)
Figure CAVAC Anthrax Vaccines Sales Market Share in EMEA (2013-2018)
Figure CAVAC Anthrax Vaccines Revenue Market Share in EMEA (2013-2018)
Table Rosenbusch Anthrax Vaccines Basic Information List
Table Agrovet Anthrax Vaccines Basic Information List
Table Vecol Anthrax Vaccines Basic Information List
Table CVCRI Anthrax Vaccines Basic Information List
Table IVPM Anthrax Vaccines Basic Information List
Table Prondil Anthrax Vaccines Basic Information List
Table CDV Anthrax Vaccines Basic Information List
Table Indian Immunologicals Anthrax Vaccines Basic Information List
Table Botswana Vaccine Institute Anthrax Vaccines Basic Information List
Table Ceva Santé Animale Anthrax Vaccines Basic Information List
Table Intervac Anthrax Vaccines Basic Information List
Table JOVAC Anthrax Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anthrax Vaccines
Figure Manufacturing Process Analysis of Anthrax Vaccines
Figure Anthrax Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2017
Table Major Buyers of Anthrax Vaccines
Table Distributors/Traders List
Figure EMEA Anthrax Vaccines Sales (M Doses) and Growth Rate Forecast (2018-2025)
Figure EMEA Anthrax Vaccines Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Anthrax Vaccines Price (USD/Doses) and Trend Forecast (2018-2025)
Table EMEA Anthrax Vaccines Sales (M Doses) Forecast by Region (2018-2025)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Region (2018-2025)
Table EMEA Anthrax Vaccines Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Anthrax Vaccines Revenue Market Share Forecast by Region (2018-2025)
Table Europe Anthrax Vaccines Sales (M Doses) Forecast by Countries (2018-2025)
Figure Europe Anthrax Vaccines Sales Market Share Forecast by Countries (2018-2025)
Table Europe Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Anthrax Vaccines Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Anthrax Vaccines Sales (M Doses) Forecast by Countries (2018-2025)
Figure Middle East Anthrax Vaccines Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Anthrax Vaccines Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Anthrax Vaccines Sales (M Doses) Forecast by Countries (2018-2025)
Figure Africa Anthrax Vaccines Sales Market Share Forecast by Countries (2018-2025)
Table Africa Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Anthrax Vaccines Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Anthrax Vaccines Sales (M Doses) Forecast by Type (2018-2025)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Type (2018-2025)
Table EMEA Anthrax Vaccines Sales (M Doses) Forecast by Application (2018-2025)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources